MICROBPLEX

MicroBplex, Inc. is an in vitro diagnostics biotechnology company based in Atlanta, GA. We formed MicroBplex to develop and commercialize a novel patent - pending diagnostic technology conceived by our scientific founders, Drs. Frances Eun-Hyung Lee (Emory University) and John L. Daiss (University of Rochester), based on detecting nascent antibody secreting cells (ASCs)... MicroBplex has developed a new class of infectious disease in vitro diagnostic products that provide early detection of infection, assess therapeutic effectiveness, predict immune protection, and do not require access to the infectious organism... Infectious disease diagnostics constitute a large, inadequately served medical need. Most current diagnostic approaches require obtaining a patient specimen that contains the pathogen for subsequent identification by culture, molecular amplification, or mass spectrometry. These methods are prone to false negatives due to poor sampling or false positives due to..

Also known as: MicroBplex, Inc.